Publication dates

Biogen Idec Industry, September 2014 Market Research & Statistics

You might be interested in: drug, water, biotech, more »

1-10 of about 700 reports for Biogen Idec

Download Unlimited Documents from Trusted Public Sources

Life Sciences Analysis in the US - Forecast

  • Life Science Market Overview
  • January 2012
    8 pages
  • Life Sciences  

  • United States  

View report >

Pathology Description in the US - Forecast

  • Observer Jan 2013d
  • January 2012
    38 pages
  • Blood Disease  

    Hemophilia  

  • United States  

View report >

Pathology Description

  • Promotional Trends Report
  • November 2012
    20 pages
  • Multiple Sclero...  

View report >

Analyst Report, October 2012

  • Rumours of Takeover Circle Pharmaxis
  • October 2012
    7 pages
  • United States  

    Australia  

    France  

View report >

Global Drug Demand Forecast

  • Orphan Drug Report 2013
  • January 2013
    19 pages
  • Drug  

  • World  

    Europe  

    United States  

View report >

Pharmaceutical Markets in the US - Forecast

  • Pharma Outlook
  • January 2013
    42 pages
  • Pharmaceutical  

  • United States  

    Europe  

View report >

Pharmaceutical Markets in the US - Forecast

  • Pharma Outlook
  • January 2013
    40 pages
  • Pharmaceutical  

  • United States  

    Europe  

View report >

Global Pharmaceutical Markets - Forecast

  • Embracing the Patent Cliff
  • January 2012
    39 pages
  • Pharmaceutical  

    Drug And Medica...  

  • World  

    United States  

    Japan  

View report >

Analyst Report, July 2014

  • Morning News call
  • July 2014
    6 pages
  • United States  

    China  

View report >

Global Prescription Drug Markets - Forecast

  • World Preview 2014, Outlook to 2020
  • January 2014
    39 pages
  • Prescription Dr...  

    Prescription Dr...  

  • World  

    United States  

    Japan  

View report >
About 300 reports for Biogen Idec

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 10 995)

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

  • $ 4 995
  • Industry report
  • September 2014
  • by GBI Research

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting Summary GBI Research, the leading business intelligence provider, ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.